How GLP-1 Medications Affect Sedation in a Dental Setting

What Are GLP-1 Medications?

If you're taking Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), Saxenda (liraglutide), or another GLP-1 receptor agonist for diabetes, weight loss, or heart health, there are important things you need to know before any periodontal procedure that involves sedation.

GLP-1 receptor agonists (commonly called GLP-1s) are a class of injectable medications that mimic a natural hormone your body produces after eating. They work by stimulating insulin release to lower blood sugar, acting on appetite centers in the brain to reduce hunger and promote feelings of fullness, and, critically for your dental care, slowing down how quickly your stomach empties food into your intestines.

This slowing of gastric (stomach) emptying is actually one of the main ways these medications help with weight loss and blood sugar control. But it also creates specific safety concerns for dental procedures, and it can affect how well other medications you take by mouth are absorbed. About 1 in 8 U.S. adults now uses a GLP-1 medication, so this is information your periodontal team needs you to understand.

What "Delayed Gastric Emptying" Means for You

In a healthy digestive system, your stomach processes a meal and moves it into the small intestine within about 4–5 hours. GLP-1 medications slow this process down significantly; depending on the specific medication, the dose, and how long you've been taking it, gastric emptying can be delayed by 1 to 3 hours or more beyond normal.

What does this mean in practical terms? Food stays in your stomach much longer than it normally would. Research has shown that even after an overnight fast, patients taking semaglutide (Ozempic/Wegovy) had solid food remaining in their stomachs 70% of the time, compared to only 10% of patients not taking the medication. In some cases, undigested food has been found in the stomachs of GLP-1 patients days after they stopped eating, a finding that has significant safety implications for any procedure involving sedation.

Who Is at Higher Risk?

The delayed gastric emptying effect of GLP-1 medications is strongest during the dose-escalation phase (when your dose is being increased), at higher doses, and with weekly formulations. It tends to lessen somewhat over time with long-term use (a phenomenon called tachyphylaxis). However, for longer-acting GLP-1s like semaglutide, studies show it can take several weeks after stopping the medication for gastric emptying to fully return to normal.

Why This Matters for Sedation: The Aspiration Risk

This is the most important section of this guide. Please read it carefully.

When you are sedated, whether with oral sedation, IV sedation, or general anesthesia, your body's protective reflexes are suppressed. Normally, if food or liquid were to come up from your stomach into your throat, your gag reflex and cough reflex would protect your airway. Under sedation, these reflexes are diminished or absent.

If food is still sitting in your stomach when you are sedated, there is a risk that it can come back up (regurgitate) and be inhaled into your lungs. This is called pulmonary aspiration, and it is a potentially life-threatening emergency that can cause severe pneumonia, respiratory failure, and in rare cases, death. This is the reason your dental team asks you not to eat before sedation. The goal is to ensure your stomach is empty.

The problem with GLP-1 medications: Because these drugs slow gastric emptying so dramatically, the standard fasting rules that work for other patients may not be enough for you. Even patients who follow standard fasting instructions (nothing to eat for 8 hours) have been found to still have significant amounts of food in their stomachs at the time of their procedure. Multiple case reports and clinical studies have documented aspiration events in GLP-1 patients who believed they had fasted appropriately.

Critical Safety Warning: IV Sedation

If you are scheduled for a procedure with IV sedation (intravenous sedation), you MUST stop your GLP-1 medication for at least one week before the procedure. This is consistent with the American Society of Anesthesiologists' recommendation that patients on weekly GLP-1 dosing hold their medication for one week prior to elective procedures. Because GLP-1 medications slow gastric emptying, food can remain in your stomach much longer than normal; even on a complete fast, food has been observed in patients' stomachs for days after they stopped eating while on GLP-1 therapy. Standard fasting cannot reliably guarantee an empty stomach while these medications are still active. Your safety is our absolute priority: sedating a patient with food still in their stomach is extremely dangerous.

If You Are Having Oral Sedation (Halcion)

Triazolam (Halcion) is the oral sedation medication most commonly used in periodontal surgery. It is taken by mouth before your appointment to help you feel relaxed and comfortable during the procedure. For patients taking GLP-1 medications, there are several important modifications to ensure both your safety and the effectiveness of the sedation.

Dietary Preparation Before Surgery

Avoid fatty, hard-to-digest foods for multiple days before your procedure. Because GLP-1 medications delay gastric emptying, heavy foods, particularly fatty meals, red meat, fried foods, and large portions, can remain in your stomach for much longer than you expect. To give your stomach the best chance of being empty by the time of your procedure, we recommend switching to a light, easily digestible diet (soups, smoothies, lean proteins, cooked vegetables, toast) for at least 2–3 days before surgery.

NPO (Nothing by Mouth) for 8 Hours

You must have nothing to eat or drink for at least 8 hours before taking your Halcion. NPO (a medical term from the Latin "nil per os" meaning nothing by mouth) is essential for your safety. This includes all food, beverages (other than a small sip of water to take the medication), candy, gum, and mints. The 8-hour fasting period helps reduce the amount of material in your stomach, though it may not completely eliminate retained food in GLP-1 patients, which is why the dietary preparation in the days before is equally important.

How to Take Your Halcion for Best Absorption

Crush the Halcion tablet and place it under your tongue (sublingual administration). This is a critical modification for patients on GLP-1 medications. Because GLP-1s slow gastric emptying, a pill that is swallowed normally and must dissolve in the stomach may not be absorbed predictably; the medication could sit in your stomach without being properly processed, resulting in either delayed sedation, incomplete sedation, or an unpredictable response. Crushing the tablet and placing the powder under your tongue allows the medication to be absorbed directly through the mucous membranes in your mouth, bypassing the stomach entirely. This ensures more reliable and consistent absorption regardless of your gastric emptying status.

Summary: Oral Sedation Checklist for GLP-1 Patients

• Light, easily digestible foods only for 2–3 days before surgery (no fatty, heavy meals)
• Nothing by mouth (NPO) for at least 8 hours before taking Halcion
• Crush the Halcion tablet and place it under your tongue
• A small sip of water is okay to help with the medication
• Report any nausea, vomiting, bloating, or abdominal discomfort to Dr. Yant before the procedure

If You Are Having IV Sedation

IV (intravenous) sedation provides a deeper level of sedation than oral Halcion. The medication is delivered directly into your bloodstream through an IV line, producing a state in which your protective airway reflexes are more significantly reduced. Because of this, the aspiration risk is higher with IV sedation than with oral sedation, and the precautions must be more stringent.

Mandatory: Stop GLP-1 Medication 1 Week Before IV Sedation

You must discontinue your GLP-1 medication at least one week before any procedure involving IV sedation. For patients on weekly dosing (such as semaglutide or tirzepatide), this means skipping your scheduled dose in the week before surgery. The half-life of these medications is approximately 5–7 days, and holding for one week allows a meaningful reduction in the drug's effect on gastric motility. Please coordinate with the physician who prescribes your GLP-1 medication before stopping it, as they may need to adjust your diabetes or weight management plan during this period.

Example: IV Sedation Timing for a Wednesday, March 25th Procedure

Suppose your IV sedation surgery is scheduled for Wednesday, March 25th at 10:00 AM, and you normally take your weekly Ozempic injection on Fridays. Here is what your preparation would look like:

• Friday, March 14th: Take your last Ozempic injection as normal. This is your final dose before surgery.
• Friday, March 21st: SKIP this dose. Do not take your Ozempic injection. This ensures you have been off the medication for at least one full week before your procedure.
• Sunday, March 23rd – Tuesday, March 24th: Light, easily digestible foods only for the 2–3 days before surgery. No fatty meals, fried foods, or large portions.
• Tuesday, March 24th by 2:00 AM at the latest (8 hours before 10:00 AM): Stop all food and drink. In practice, finish a light dinner Tuesday evening and have nothing after that.
• Wednesday, March 25th: Arrive for your 10:00 AM procedure. Nothing to eat or drink.
• After surgery: Dr. Yant and your prescribing physician will advise you when to resume your Ozempic injections, typically at your next regularly scheduled dose (Friday, March 28th) once you are recovering normally.

On the day of your IV sedation procedure, you must also be NPO (nothing by mouth) for at least 8 hours, following the same dietary preparation described above. If you experience any GI symptoms, such as nausea, vomiting, bloating, abdominal fullness, or feeling like food is sitting in your stomach, call our office immediately. We may need to reschedule your procedure for your safety.

How GLP-1s Can Affect Your Other Medications

The same gastric emptying delay that creates sedation safety concerns also has implications for other medications you take by mouth. When your stomach empties more slowly, oral medications may take longer to be absorbed, may reach lower peak levels in your bloodstream, or may have unpredictable effects.

The FDA-approved prescribing information for Ozempic (semaglutide) explicitly states that the medication delays gastric emptying and may impact the absorption of other oral medications taken at the same time. Research has confirmed that GLP-1 medications can reduce the peak blood concentration of co-administered oral drugs by 13–56%, depending on the specific medication. While for most daily medications this delay does not cause clinically significant problems (because the total amount of drug absorbed over time is often similar), there are specific situations in your periodontal care where this matters:

• Pre-surgical medications: Antibiotics, anti-inflammatory medications, or other drugs prescribed before your procedure may take longer to reach therapeutic levels or may not be absorbed as predictably as expected.
• Pain medications: Oral pain medications taken after surgery may have delayed onset and reduced peak effectiveness.
• Halcion and other oral sedatives: As discussed above, this is why we recommend sublingual (under-the-tongue) administration for patients on GLP-1 therapy.

What You Can Do

Always tell Dr. Yant and their team which GLP-1 medication you are taking, the dose, and how long you have been on it. This allows us to adjust your treatment plan accordingly, including modifying the route of medication delivery when needed (for example, prescribing injectable or sublingual versions of medications rather than pills that must pass through your stomach).

GLP-1 Medications and Your Periodontal Health

Beyond the sedation and medication absorption considerations above, GLP-1 medications have several connections to your periodontal health that are worth understanding:

Diabetes, Blood Sugar Control, and Gum Disease

For patients taking GLP-1s for type 2 diabetes, improved blood sugar control is directly beneficial for your gums. Uncontrolled diabetes (particularly HbA1c above 7–8%) is a major risk factor for periodontal disease progression, impaired healing after treatment, and implant failure. By helping you achieve better glycemic control, GLP-1 medications may indirectly support better periodontal outcomes. This is a significant positive effect, and it's one of the reasons we do not want you to stop your GLP-1 medication longer than absolutely necessary for sedation safety.

Weight Loss and Inflammation

Obesity is associated with increased systemic inflammation, which can worsen periodontal disease. The weight loss achieved with GLP-1 therapy may contribute to reduced overall inflammation, potentially improving your body's ability to manage and respond to gum disease. While direct clinical studies on GLP-1 use and periodontal outcomes are still in their early stages, the metabolic improvements associated with these medications are generally favorable for oral health.

Nausea and Oral Hygiene

GLP-1 medications commonly cause nausea, particularly during the dose-escalation phase. If nausea is causing you to avoid brushing your teeth or making it difficult to maintain your oral hygiene routine, please let your periodontal team know. We can recommend strategies to maintain your oral health during periods of nausea, including specific rinses and modified brushing techniques.

Dry Mouth

Some patients on GLP-1 medications report reduced salivary flow or dry mouth. Saliva is one of your body's primary defenses against both tooth decay and gum disease; it neutralizes acids, washes away bacteria, and delivers minerals that protect your teeth. If you are experiencing dry mouth, let us know so we can recommend products and strategies to protect your oral health.

Your Pre-Procedure Checklist

For All Patients on GLP-1 Medications

• Tell Dr. Yant you are taking a GLP-1 medication, the specific drug name, dose, and how long you have been on it.
• Report any GI symptoms: nausea, vomiting, bloating, feeling of food sitting in your stomach, or abdominal pain.
• Switch to light, easily digestible foods (soups, smoothies, lean proteins, cooked vegetables, toast) for at least 2–3 days before any procedure involving sedation.
• Follow all NPO (nothing by mouth) instructions exactly as directed.

If Having Oral Sedation (Halcion)

• Light diet for 2–3 days before.
• NPO (nothing by mouth) for at least 8 hours before taking Halcion.
• Crush the Halcion tablet and place the powder under your tongue for absorption. Do not swallow it whole.
• A small sip of water is okay to help with the medication.

If Having IV Sedation

• Stop your GLP-1 medication at least 1 week before the procedure.
• Coordinate with your prescribing physician about stopping and restarting the medication.
• Light diet for 2–3 days before.
• NPO (nothing by mouth) for at least 8 hours before the procedure.
• If you experience any GI symptoms on the day of the procedure, call us immediately; we may need to reschedule.

Sources

This guide is based on published guidelines and peer-reviewed research from leading medical organizations and journals.

• American Society of Anesthesiologists (ASA). (2023). Consensus-based guidance on preoperative management of patients on GLP-1 receptor agonists.
• American Society of Anesthesiologists, et al. (2024). Multi-society clinical practice guidance for the safe use of GLP-1 receptor agonists in the perioperative period. Surgery for Obesity and Related Diseases, 20(11), 1281–1289.
• Camilleri, M. (2024). Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists. Journal of Clinical Endocrinology & Metabolism, 110(1), 1–14.
• FDA. (2025). Ozempic (semaglutide) prescribing information.
• Joshi, G. P., et al. (2023). American Society of Anesthesiologists consensus-based guidance on preoperative management of patients on GLP-1 receptor agonists.
• Klein, S. R., & Hobai, I. A. (2023). Semaglutide, delayed gastric emptying, and intraoperative pulmonary aspiration: a case report. Canadian Journal of Anesthesia, 70, 1394–1396.
• Silveira, S. Q., et al. (2023). Gastric emptying in patients taking GLP-1 receptor agonists. Anesthesiology, 139(6), 816–819.